NYSE:DEN • US24790A1016
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Denbury Inc (DEN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-08-28 | Jefferies | Downgrade | Buy -> Hold |
| 2023-08-17 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2023-08-11 | Stifel | Maintains | Hold -> Hold |
| 2023-07-25 | Capital One | Downgrade | Overweight -> Equal-Weight |
| 2023-07-24 | Stifel | Downgrade | Buy -> Hold |
| 2023-07-21 | Johnson Rice | Downgrade | Accumulate -> Hold |
| 2023-06-15 | JP Morgan | Initiate | Neutral |
| 2023-04-27 | Stifel | Maintains | Buy |
| 2023-03-30 | Stifel | Maintains | Buy |
| 2022-12-15 | B of A Securities | Initiate | Underperform |
| 2022-11-22 | Roth Capital | Upgrade | Neutral -> Buy |
| 2022-10-25 | Roth Capital | Downgrade | Buy -> Neutral |
| 2022-10-20 | Stifel | Reiterate | Buy |
| 2022-10-19 | Jefferies | Initiate | Buy |
| 2022-09-20 | Keybanc | Initiate | Overweight |
| 2022-07-19 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2022-05-10 | Citigroup | Initiate | Buy |
| 2022-02-18 | Roth Capital | Upgrade | Neutral -> Buy |
| 2022-01-20 | Keybanc | Maintains | Overweight |
| 2022-01-10 | B of A Securities | Initiate | Neutral |
| 2021-12-14 | Wolfe Research | Initiate | Outperform |
| 2021-11-23 | Tudor Pickering | Initiate | Buy |
| 2021-11-10 | Keybanc | Maintains | Overweight |
| 2021-11-03 | Keybanc | Maintains | Overweight |
| 2021-10-19 | Keybanc | Maintains | Overweight |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 750.7M -41.12% | 1.258B 67.60% | 1.715B 36.28% | 1.418B -17.30% | 1.555B 9.66% | 1.478B -4.95% | N/A | |
| EBITDA YoY % growth | 174.5M -69.35% | 578.9M 231.75% | 889.2M 53.60% | 608.14M -31.61% | 706.23M 16.13% | 737.91M 4.49% | 1.024B 38.77% | |
| EBIT YoY % growth | -59.9M -117.85% | 428.3M 815.03% | 737.8M 72.26% | 397.6M -46.11% | 473.49M 19.09% | 369.66M -21.93% | N/A | |
| Operating Margin | -7.98% | 34.04% | 43.03% | 28.04% | 30.45% | 25.01% | N/A | |
| EPS YoY % growth | N/A -140.15% | 2.55 1,687.89% | 6.76 165.10% | 5.48 -18.87% | 6.56 19.62% | 6.87 4.77% | N/A |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.43 -24.68% | 1.60 8.01% | 1.56 14.47% | 1.58 49.07% | 1.67 16.95% | 1.71 6.98% | 1.27 -18.25% | 1.19 -24.58% | 1.17 -29.99% | 1.22 -28.54% |
| Revenue Q2Q % growth | 357.44M -18.67% | 382.15M 0.25% | 376.19M 10.32% | 378.95M 15.18% | 398.18M 11.40% | 405.01M 5.98% | 374.71M -0.39% | 366.63M -3.25% | 365.62M -8.18% | 371.68M -8.23% |
| EBITDA Q2Q % growth | 158.11M -45.82% | 173.32M -38.32% | 172.69M 25.78% | 174.88M 7.82% | 174.43M 10.32% | 176.96M 2.10% | 172.24M -0.26% | 170.7M -2.39% | 170.13M -2.47% | 170.3M -3.76% |
| EBIT Q2Q % growth | 100.39M -45.26% | 117.13M -9.62% | 111.37M 16.86% | 111.2M 57.95% | 124.57M 24.09% | 128.07M 9.34% | 94.94M -14.75% | 89.89M -19.16% | 89.89M -27.84% | 94.94M -25.87% |
All data in USD
11 analysts have analysed DEN and the average price target is 92.57 USD. This implies a price increase of 4.4% is expected in the next year compared to the current price of 88.66.
Denbury Inc (DEN) will report earnings on 2024-02-21, after the market close.
The consensus EPS estimate for the next earnings of Denbury Inc (DEN) is 1.43 USD and the consensus revenue estimate is 357.44M USD.
The number of analysts covering Denbury Inc (DEN) is 11.